|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Arnold M, Soerjomataram I, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar
|
|
3
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dixit VM, Green S, Sarma V, Holzman LB,
Wolf FW, O'Rourke K, Ward PA, Prochownik EV and Marks RM: Tumor
necrosis factor-α induction of novel gene products in human
endothelial cells including a macrophage-specific chemotaxin. J
Biol Chem. 265:2973–2978. 1990.PubMed/NCBI
|
|
6
|
Opipari AW Jr, Boguski MS and Dixit VM:
The A20 cDNA induced by tumor necrosis factor α encodes a novel
type of zinc finger protein. J Biol Chem. 265:14705–14708.
1990.PubMed/NCBI
|
|
7
|
Krikos A, Laherty CD and Dixit VM:
Transcriptional activation of the tumor necrosis factor α-inducible
zinc finger protein, A20, is mediated by kappa B elements. J Biol
Chem. 267:17971–17976. 1992.PubMed/NCBI
|
|
8
|
Wertz IE, O'Rourke KM, Zhou H, Eby M,
Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, et al:
De-ubiquitination and ubiquitin ligase domains of A20 downregulate
NF-kappaB signalling. Nature. 430:694–699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bosanac I, Wertz IE, Pan B, Yu C, Kusam S,
Lam C, Phu L, Phung Q, Maurer B, Arnott D, et al: Ubiquitin binding
to A20 ZnF4 is required for modulation of NF-κB signaling. Mol
Cell. 40:548–557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Opipari AW Jr, Hu HM, Yabkowitz R and
Dixit VM: The A20 zinc finger protein protects cells from tumor
necrosis factor cytotoxicity. J Biol Chem. 267:12424–12427.
1992.PubMed/NCBI
|
|
11
|
Song HY, Rothe M and Goeddel DV: The tumor
necrosis factor-inducible zinc finger protein A20 interacts with
TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci
USA. 93:6721–6725. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heyninck K, De Valck D, Vanden Berghe W,
Van Criekinge W, Contreras R, Fiers W, Haegeman G and Beyaert R:
The zinc finger protein A20 inhibits TNF-induced
NF-kappaB-dependent gene expression by interfering with an RIP- or
TRAF2-mediated transactivation signal and directly binds to a novel
NF-kappaB-inhibiting protein ABIN. J Cell Biol. 145:1471–1482.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang SQ, Kovalenko A, Cantarella G and
Wallach D: Recruitment of the IKK signalosome to the p55 TNF
receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor
stimulation. Immunity. 12:301–311. 2000. View Article : Google Scholar
|
|
14
|
Lee EG, Boone DL, Chai S, Libby SL, Chien
M, Lodolce JP and Ma A: Failure to regulate TNF-induced NF-kappaB
and cell death responses in A20-deficient mice. Science.
289:2350–2354. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Valck D, Jin DY, Heyninck K, Van de
Craen M, Contreras R, Fiers W, Jeang KT and Beyaert R: The zinc
finger protein A20 interacts with a novel anti-apoptotic protein
which is cleaved by specific caspases. Oncogene. 18:4182–4190.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma A and Malynn BA: A20: Linking a complex
regulator of ubiquitylation to immunity and human disease. Nat Rev
Immunol. 12:774–785. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hadisaputri YE, Miyazaki T, Suzuki S,
Yokobori T, Kobayashi T, Tanaka N, Inose T, Sohda M and Kuwano H:
TNFAIP8 overexpression: Clinical relevance to esophageal squamous
cell carcinoma. Ann Surg Oncol. 19(Suppl 3): S589–S596. 2012.
View Article : Google Scholar
|
|
18
|
Wang MC, Liu SX and Liu PB: Gene
expression profile of multiple myeloma cell line treated by
realgar. J Exp Clin Cancer Res. 25:243–249. 2006.PubMed/NCBI
|
|
19
|
Vendrell JA, Ghayad S, Ben-Larbi S,
Dumontet C, Mechti N and Cohen PA: A20/TNFAIP3, a new
estrogen-regulated gene that confers tamoxifen resistance in breast
cancer cells. Oncogene. 26:4656–4667. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Q, Yuan L, Liu Z, Yin J, Jiang X and
Lu J: Expression of A20 is reduced in pancreatic cancer tissues. J
Mol Histol. 43:319–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong B, Lv G, Wang Q, Wei F, Bellail AC,
Hao C and Wang G: Targeting A20 enhances TRAIL-induced apoptosis in
hepatocellular carcinoma cells. Biochem Biophys Res Commun.
418:433–438. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang M and Li S: Bladder polypoid
cystitis-derived A20 associates with tumorigenesis. Cell Biochem
Biophys. 67:669–673. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ghadban T, Schmidt-Yang M, Uzunoglu FG,
Perez DR, Tsui TY, El gammal AT, Erbes PJ, Zilbermints V, Wellner
U, Pantel K, et al: An A/C germline single-nucleotide polymorphism
in the TNFAIP3 gene is associated with advanced disease stage and
survival in only surgically treated esophageal cancer. J Hum Genet.
59:661–666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lademann U, Kallunki T and Jäättelä M: A20
zinc finger protein inhibits TNF-induced apoptosis and stress
response early in the signaling cascades and independently of
binding to TRAF2 or 14-3-3 proteins. Cell Death Differ. 8:265–272.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Daniel S, Arvelo MB, Patel VI, Longo CR,
Shrikhande G, Shukri T, Mahiou J, Sun DW, Mottley C, Grey ST, et
al: A20 protects endothelial cells from TNF-, Fas-, and NK-mediated
cell death by inhibiting caspase 8 activation. Blood.
104:2376–2384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hjelmeland AB, Wu Q, Wickman S, Eyler C,
Heddleston J, Shi Q, Lathia JD, Macswords J, Lee J, McLendon RE, et
al: Targeting A20 decreases glioma stem cell survival and tumor
growth. PLoS Biol. 8:e10003192010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun X, Chen E, Dong R, Chen W and Hu Y:
Nuclear factor (NF)-κB p65 regulates differentiation of human and
mouse lung fibroblasts mediated by TgF-β. Life Sci. 122:8–14. 2015.
View Article : Google Scholar
|
|
28
|
Murtas D, Maric D, De Giorgi V, Reinboth
J, Worschech A, Fetsch P, Filie A, Ascierto ML, Bedognetti D, Liu
Q, et al: IRF-1 responsiveness to IFN-γ predicts different cancer
immune phenotypes. Br J Cancer. 109:76–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Codd JD, Salisbury JR, Packham G and
Nicholson LJ: A20 RNA expression is associated with
undifferentiated nasopharyngeal carcinoma and poorly differentiated
head and neck squamous cell carcinoma. J Pathol. 187:549–555. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
da Silva CG, Studer P, Skroch M, Mahiou J,
Minussi DC, Peterson CR, Wilson SW, Patel VI, Ma A, Csizmadia E, et
al: A20 promotes liver regeneration by decreasing SOCS3 expression
to enhance IL-6/STAT3 proliferative signals. Hepatology.
57:2014–2025. 2013. View Article : Google Scholar :
|
|
31
|
Murphy SF, Rhee L, Grimm WA, Weber CR,
Messer JS, Lodolce JP, Chang JE, Bartulis SJ, Nero T, Kukla RA, et
al: Intestinal epithelial expression of TNFAIP3 results in
microbial invasion of the inner mucus layer and induces colitis in
IL-10-deficient mice. Am J Physiol Gastrointest Liver Physiol.
307:G871–G882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moll HP, Lee A, Minussi DC, da Silva CG,
Csizmadia E, Bhasin M and Ferran C: A20 regulates atherogenic
interferon (IFN)-γ signaling in vascular cells by modulating basal
IFNβ levels. J Biol Chem. 289:30912–30924. 2014. View Article : Google Scholar : PubMed/NCBI
|
